Depressive Disorders
Research activity in major depressive disorder includes adjunctive treatment strategies aimed at improving depressive symptoms, maintaining response over time, and evaluating longer-term tolerability in adults with persistent mood symptoms.
- Major depressive disorder
- Adjunctive antidepressant therapy
- Relapse prevention
The sponsor’s work in this area centers on treatment-resistant and recurrent depression, with emphasis on symptom control and sustained clinical benefit.
Schizophrenia and Related Psychotic Symptoms
Clinical research in schizophrenia spans both outpatient and inpatient settings, with attention to behavioral and psychological symptoms, inadequate response to antipsychotic treatment, and long-term safety of adjunctive options.
- Schizophrenia
- Behavioral and psychological symptoms
- Adjunctive antipsychotic treatment
Trials also address symptom management in adults requiring hospital-based care, reflecting a focus on complex psychiatric illness.
Congenital Adrenal Hyperplasia
Studies in classic congenital adrenal hyperplasia and broader congenital adrenal hyperplasia evaluate adrenal hormone control, glucocorticoid-sparing approaches, and treatment use in very young pediatric patients.
- Classic congenital adrenal hyperplasia
- Adrenal steroid regulation
- Pediatric endocrine disorders
This area includes interest in adrenal androgen control and early-life management of endocrine disease.
Movement Disorders and Dyskinesia
The sponsor supports research on movement disorders, including dyskinesia due to cerebral palsy and chorea in pediatric and adult populations, with evaluation of symptom reduction and functional impact.
- Movement disorders
- Dyskinesia due to cerebral palsy
- Chorea
These studies reflect a therapeutic interest in abnormal involuntary movement syndromes across age groups.
Neurological and Neuropsychiatric Conditions
Additional research extends across broader neurological and neuropsychiatric conditions, including epilepsy and related central nervous system disorders, with exploratory work in healthy participants supporting neuropharmacology programs.
- Epilepsy
- Neurological and neuropsychiatric conditions
- Neuropharmacology
The portfolio includes interest in central nervous system symptom modulation and treatment development across neurological and psychiatric domains.
